secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2022-05-19T23:59:59+00:00
Accession:  0001171520-22-000313
Event type: regulatory
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro receives Nasdaq non-compliance notice, cures by reconstituting committees
--------------------------------------------------------------------------------

- Nasdaq notified ClearPoint Neuro on May 19, 2022 of non-compliance with audit and compensation committee independence rules due to Matthew Klein, M.D. not being independent.
- Board reconstituted committees on May 13, 2022: Audit now has Pascal Girin, Lynnette Fallon, R. John Fletcher; Compensation has B. Kristine Johnson and Timothy Richards.
- Nasdaq confirmed the company now complies with Listing Rule 5605 following committee changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000117152022000313/0001171520-22-000313-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000117152022000313/eps10266.htm
  HTML page:      https://secwatch.observer/filing/0001171520-22-000313

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer